+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

HIV/AIDS Drugs Market Research Reports

HIV Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

HIV Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 177 Pages
  • Global
From
India Lopinavir & Ritonavir Market, Competition, Forecast & Opportunities, 2019-2029 - Product Thumbnail Image

India Lopinavir & Ritonavir Market, Competition, Forecast & Opportunities, 2019-2029

  • Report
  • October 2023
  • 88 Pages
  • India
From
HIV-associated Lipodystrophy Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Thumbnail Image

HIV-associated Lipodystrophy Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • October 2023
  • 190 Pages
  • Global
From
United States Pre-Exposure Prophylaxis (PrEP) Market, Competition, Forecast and Opportunities, 2018-2028 - Product Thumbnail Image

United States Pre-Exposure Prophylaxis (PrEP) Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • October 2023
  • 78 Pages
  • United States
From
HIV Drugs Market - Product Thumbnail Image

HIV Drugs Market

  • Report
  • June 2023
  • 158 Pages
  • Global
From
HIV Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

HIV Drugs Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal - Product Thumbnail Image

HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal

  • Report
  • December 2019
  • 63 Pages
  • Global
From
Global HIV Treatment Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global HIV Treatment Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
US HIV Market and Competitive Landscape - 2022 - Product Thumbnail Image

US HIV Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • Report
  • August 2022
  • 95 Pages
  • Global
From
Viread - API Insight, 2022 - Product Thumbnail Image

Viread - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Sustiva - API Insight, 2022 - Product Thumbnail Image

Sustiva - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Norvir SEC - API Insight, 2022 - Product Thumbnail Image

Norvir SEC - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Kaletra - API Insight, 2022 - Product Thumbnail Image

Kaletra - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Isentress - API Insight, 2022 - Product Thumbnail Image

Isentress - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Selzentry - API Insight, 2022 - Product Thumbnail Image

Selzentry - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Truvada - API Insight, 2022 - Product Thumbnail Image

Truvada - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Prezista - API Insight, 2022 - Product Thumbnail Image

Prezista - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Reyataz - API Insight, 2022 - Product Thumbnail Image

Reyataz - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Combivir - API Insight, 2022 - Product Thumbnail Image

Combivir - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Loading Indicator

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus. The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more